Andreas Hadjimichael, 10% Owner at Karyopharm Therapeutics Inc. (KPTI), sold 272,784 shares at $43.74 ($11.5M) on 2014-11-06, disclosed to the SEC on 2014-11-06.
Open-market sale of $11.5M KPTI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.38 | 91,100 | $3.8M | 32.8% |
| 2 | $42.55 | 5,700 | $243K | 2.1% |
| 3 | $42.02 | 107,934 | $4.5M | 39.5% |
| 4 | $43.19 | 66,650 | $2.9M | 25.1% |
| 5 | $43.74 | 1,400 | $61K | 0.5% |
| Total | $42.11 avg | 272,784 |
| $11.5M |
| 100% |
| Filing → |
| KPTI | SELL | 2018-07-23 | $4.8M | — | Filing → |
| KPTI | SELL | 2016-06-27 | $302K | — | Filing → |
| KPTI | SELL | 2016-05-23 | $298K | — | Filing → |